ArticleJournal of general internal medicine2026
Inequity in Continuous Glucose Monitor (CGM) Prescribing Behaviors in Primary Care.
Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Beyond Coverage Expansion: Exploring Persistent Barriers to CGM Utilization in the Clinical Environment.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Article
- Primary Care-Initiated Continuous Glucose Monitoring in Adults With Insulin-Treated Diabetes.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundContinuous glucose monitoring (CGM) has become a standard of care for diabetes management, yet its adoption in primary care remains limited where the majority of people with diabetes are served. Examining contributors to CGM prescriptions in primary care may identify new targets for intervention that could improve diabetes population health.
objectiveTo determine factors associated with CGM prescription by primary care providers (PCPs) in a safety-net primary care practice network serving over 11,000 adults with insulin-treated type 2 diabetes.
designRetrospective cohort study. PATIENTS: Adults with type 2 diabetes treated with insulin with at least one primary care visit between July 31, 2020, and July 31, 2023, in a safety-net primary care clinic network in the Bronx, NY. MAIN MEASURES: Primary outcome was first-time CGM prescription by PCPs. Multivariable analysis was performed using cause-specific Cox regression, with death and prescriptions by endocrinology treated as censoring events.
resultsAmong 11,037 insulin-treated patients (mean age 61 ± 14 years; 56% female; 44% Hispanic, 39% non-Hispanic Black), 17% received first-time CGM prescriptions from primary care, with a median monthly prescription rate of 3.1% (2.8-3.3%). Older patients, Spanish-speaking, and publicly insured had a lower likelihood of receiving CGM prescription. Conversely, patients with higher HbA1c levels, more intensive insulin regimens, and providers with more years in practice were more likely to receive CGM regardless of race-ethnicity.
conclusionsCGM prescribing rates in primary care remain low, with inequity that favored younger, English-speaking, commercially insured patients, and more experienced providers. We have highlighted gaps in workflow efficiency, language and age-appropriate training support, and trainee education as key next steps to address in order to increase CGM prescriptions in primary care practice. Addressing inequitable CGM prescribing patterns is a critical first step to elevating the standard of diabetes care in primary care practice and breaking the cascade of inequity in outcomes for underserved diabetes populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.